Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid

Phytotherapy Research

Volumn 17, Issue 1, 2003, Pages 86-88

  Plotnikov, M B ^a   Aliev, O I ^a   Maslov, M Ju ^a   Vasiliev, A S ^a   Tjukavkina, N A ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Ascorbic acid; Diquertin; Haemorheology; Myocardial infarction

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; DIQUERTIN; FIBRINOGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; MALE; NONHUMAN; RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD VISCOSITY; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERYTHROCYTE AGGREGATION; FIBRINOGEN; MALE; MYOCARDIAL INFARCTION; PHYTOTHERAPY; QUERCETIN; RATS; RATS, WISTAR;

EID: 0037275376     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1082     Document Type: Article

References (18)

1. Baluda VP, Barkagan ZC, Goldberg ED. 1980. Laboratory Methods for the Investigation of Homeostasis, (in Russian) Krasnoe Znamja, Tomsk, 192.
2. Bessis M, Mohandas NA. 1975. A diffractometric method for the measurement of cellular deformability. Blood Cells 1: 307-313.
3. Bobyreva LE. 1998. Antioxidant in complex treatment of diabetic angiopathies. Exp Clin Pharm 61: 74-80 (in Russian).
4. Dhalla AK, Hill MF, Singal PK. 1996. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28: 506-514.
5. Dobretsov GE, Petrov VA, Borschevsky GA. 1977. Influence of lipid peroxidation on the physical structure of phospholipid membranes. Voprosy Med Chem 23: 818-822.
6. Dodds AJ, Boyd MJ, Allen J, Bunnett ED, Flute PT, Dormandy JA. 1980. Changes in red cell deformability and other haemorrheological variables after myocardial infarction. Br Heart J 44: 508-511.
7. Ernst E, Krauth U, Resch KL, Paulsen HF. 1990. Does blood rheology revert to normal after myocardial infarction? Br Heart J 64: 248-250.
8. Gabrieljan ES, Akopov SA. 1985. Blood Cells and Blood Flow, (in Russian) Ajstan: Erevan, 265-272.
9. Groner W, Mohandas N, Bessis M. 1980. New optical technique for measuring erythrocyte deformability with the ektacytometer. Clin Chem 9: 1435-1442.
10. Hill MF, Singal PK. 1996. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148: 291-300.
11. Kolhir VK, Bykov VA, Baginskaja AI. et al. 1996. Antioxidant activity of a dihydroquercetin isolated from Larix gmelinii (Rupr.) Rupr. wood. Phytother Res 10: 478-482.
12. Ljusov VA, Belousov Ju B. 1977. The role of blood rheology and homeostasis in pathogenesis of the cardiac ischemic disease. Cardiologia 17: 8-13 (in Russian).
13. Maclean D, Eishbein MC, Maroco PR, Braunwald E. 1976. Drug-induced alteration in myocardial infarction size. Direct quantitation of infarction following coronary artery occlusion in the rat. Science 194: 199-208.
14. Plotnikov MB, Plotnikova TM, Vaizova OE, Aliev OI, Vaizov VX. 1994. Antihypoxants as a drug for therapy of acute and chronic cerebral ischemia. Can J Physiol Pharmacol 72: (Suppl. 1) 13.20.34.
15. Plotnikov MB, Aliev OI, Popell FV. 1997. The modification of micro colourmeter MKMF-1 for registration of erythrocyte aggregation. Clin Lab Diagn 3: 457-458 (in Russian).
16. Plotnikov MB, Markov BA, Nevzorov M Ju, Vyshlov EV. 1998. The influence of the high molecular weight polyethylene oxide on the rheological properties of blood at different periods after thrombolytic therapy in patients with myocardial infarction. Cardiologia 38: 66-67 (in Russian).
17. Plotnikova TM, Bazhenova TG, Plotnikov MB, Saratikov AS. 1997. The effect of Cerebrocrast on microcirculation in acute transient cerebral ischemia. Rus J Exp Clin Pharm 1: 58-60.
18. Sorota Y, Tanahama U, Kimura M. 1988. Cooperation of quercetin with ascorbate in protection of photosensitized lysis of human erythrocytes in the presence of hematoporphyrin. Photochem Photobiol 48: 195-199.